Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus

Sehyun Shin, Yun Hee Ku, Jian Xun Ho, Yu Kyung Kim, Jang Soo Suh, Megha Singh

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The erythrocyte deformability of blood samples, of diabetes mellitus (DM) patients with and without microangiopathic complications such as nephropathy and retinopathy, is determined and is compared with that of healthy control. The erythrocyte deformability is measured in terms of elongation index (EI) with microfluidic ektacytometer, which is very sensitive to detect changes in EI of erythrocytes due to hyperglycemic process. Each measurement of diffraction pattern of erythrocyte suspension in a highly viscous polyvinyl pyrroridone (PVP) solution in a disposable microchannel is carried out. The results show that EI is well correlated with the levels of glycated hemoglobin and creatinine, as determined from the blood samples of patients. A significant decrease in the EI in DM patients compared with that in normal control is observed. In patients with complications of chronic renal failure, end stage renal disease, retinopathy and with combination of retinopathy and nephropathy, the EI is significantly decreased in comparison with that of diabetes patients without these complications. Further reduction in EI is corresponded to the changes induced by the microangiopathy process despite the maintenance of blood glucose and glycated hemoglobin by drug therapy.

Original languageEnglish
Pages (from-to)253-261
Number of pages9
JournalClinical Hemorheology and Microcirculation
Volume36
Issue number3
Publication statusPublished - 2007 Jun 11
Externally publishedYes

Fingerprint

Erythrocyte Deformability
Type 2 Diabetes Mellitus
Glycosylated Hemoglobin A
Chronic Kidney Failure
Diabetes Mellitus
Polyvinyls
Erythrocyte Indices
Microfluidics
Blood Glucose
Creatinine
Suspensions
Erythrocytes
Maintenance
Drug Therapy

Keywords

  • Creatinine
  • Erythrocyte deformability
  • Glycated hemoglobin
  • Nephropathy
  • Retinopathy

ASJC Scopus subject areas

  • Hematology
  • Physiology

Cite this

Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. / Shin, Sehyun; Ku, Yun Hee; Ho, Jian Xun; Kim, Yu Kyung; Suh, Jang Soo; Singh, Megha.

In: Clinical Hemorheology and Microcirculation, Vol. 36, No. 3, 11.06.2007, p. 253-261.

Research output: Contribution to journalArticle

Shin, Sehyun ; Ku, Yun Hee ; Ho, Jian Xun ; Kim, Yu Kyung ; Suh, Jang Soo ; Singh, Megha. / Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. In: Clinical Hemorheology and Microcirculation. 2007 ; Vol. 36, No. 3. pp. 253-261.
@article{0d26593bda144fb8ae6c50fe92e74cb6,
title = "Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus",
abstract = "The erythrocyte deformability of blood samples, of diabetes mellitus (DM) patients with and without microangiopathic complications such as nephropathy and retinopathy, is determined and is compared with that of healthy control. The erythrocyte deformability is measured in terms of elongation index (EI) with microfluidic ektacytometer, which is very sensitive to detect changes in EI of erythrocytes due to hyperglycemic process. Each measurement of diffraction pattern of erythrocyte suspension in a highly viscous polyvinyl pyrroridone (PVP) solution in a disposable microchannel is carried out. The results show that EI is well correlated with the levels of glycated hemoglobin and creatinine, as determined from the blood samples of patients. A significant decrease in the EI in DM patients compared with that in normal control is observed. In patients with complications of chronic renal failure, end stage renal disease, retinopathy and with combination of retinopathy and nephropathy, the EI is significantly decreased in comparison with that of diabetes patients without these complications. Further reduction in EI is corresponded to the changes induced by the microangiopathy process despite the maintenance of blood glucose and glycated hemoglobin by drug therapy.",
keywords = "Creatinine, Erythrocyte deformability, Glycated hemoglobin, Nephropathy, Retinopathy",
author = "Sehyun Shin and Ku, {Yun Hee} and Ho, {Jian Xun} and Kim, {Yu Kyung} and Suh, {Jang Soo} and Megha Singh",
year = "2007",
month = "6",
day = "11",
language = "English",
volume = "36",
pages = "253--261",
journal = "Clinical Hemorheology and Microcirculation",
issn = "1386-0291",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus

AU - Shin, Sehyun

AU - Ku, Yun Hee

AU - Ho, Jian Xun

AU - Kim, Yu Kyung

AU - Suh, Jang Soo

AU - Singh, Megha

PY - 2007/6/11

Y1 - 2007/6/11

N2 - The erythrocyte deformability of blood samples, of diabetes mellitus (DM) patients with and without microangiopathic complications such as nephropathy and retinopathy, is determined and is compared with that of healthy control. The erythrocyte deformability is measured in terms of elongation index (EI) with microfluidic ektacytometer, which is very sensitive to detect changes in EI of erythrocytes due to hyperglycemic process. Each measurement of diffraction pattern of erythrocyte suspension in a highly viscous polyvinyl pyrroridone (PVP) solution in a disposable microchannel is carried out. The results show that EI is well correlated with the levels of glycated hemoglobin and creatinine, as determined from the blood samples of patients. A significant decrease in the EI in DM patients compared with that in normal control is observed. In patients with complications of chronic renal failure, end stage renal disease, retinopathy and with combination of retinopathy and nephropathy, the EI is significantly decreased in comparison with that of diabetes patients without these complications. Further reduction in EI is corresponded to the changes induced by the microangiopathy process despite the maintenance of blood glucose and glycated hemoglobin by drug therapy.

AB - The erythrocyte deformability of blood samples, of diabetes mellitus (DM) patients with and without microangiopathic complications such as nephropathy and retinopathy, is determined and is compared with that of healthy control. The erythrocyte deformability is measured in terms of elongation index (EI) with microfluidic ektacytometer, which is very sensitive to detect changes in EI of erythrocytes due to hyperglycemic process. Each measurement of diffraction pattern of erythrocyte suspension in a highly viscous polyvinyl pyrroridone (PVP) solution in a disposable microchannel is carried out. The results show that EI is well correlated with the levels of glycated hemoglobin and creatinine, as determined from the blood samples of patients. A significant decrease in the EI in DM patients compared with that in normal control is observed. In patients with complications of chronic renal failure, end stage renal disease, retinopathy and with combination of retinopathy and nephropathy, the EI is significantly decreased in comparison with that of diabetes patients without these complications. Further reduction in EI is corresponded to the changes induced by the microangiopathy process despite the maintenance of blood glucose and glycated hemoglobin by drug therapy.

KW - Creatinine

KW - Erythrocyte deformability

KW - Glycated hemoglobin

KW - Nephropathy

KW - Retinopathy

UR - http://www.scopus.com/inward/record.url?scp=34249906714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249906714&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 253

EP - 261

JO - Clinical Hemorheology and Microcirculation

JF - Clinical Hemorheology and Microcirculation

SN - 1386-0291

IS - 3

ER -